Author

Gauri G. Nagargoje

Observed name: G.G. Nagargoje

Observed institution: Mayo Clinic

OpenAlex ID: A5007900558

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

2021 · Grzegorz S. Nowakowski, Fangxin Hong, et al. · Journal of Clinical Oncology · 109

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

2018 · Lynne I. Wagner, Fengmin Zhao, et al. · Breast Cancer Research and Treatment · 92

The Use of Valeriana officinalis (Valerian) in Improving Sleep in Patients Who Are Undergoing Treatment for Cancer: A Phase III Randomized, Placebo-Controlled, Double-Blind Study (NCCTG Trial, N01C5)

2011 · Debra L. Barton, Pamela J. Atherton, et al. · The Journal of Supportive Oncology · 77

Addition of Lenalidomide to R‐chop (r2chop) Improves Outcomes in Newly Diagnosed Diffuse Large B‐cell Lymphoma (dlbcl): First Report of Ecog‐acrin1412 a Randomized Phase 2 Us Intergroup Study of R2chop Vs R‐chop

2019 · G.S. Nowakowski, F. Hong, et al. · Hematological Oncology · 35

Works count: 4

Citation count: 313

H-index: 4

I10-index: 4